Q4 2024 Earnings Call Transcript February 4, 2025 Amgen Inc. beats earnings expectations. Reported EPS is $5.31, expectations ...

All lines have been placed on mute to prevent any background noise. There will be a question-and-answer session at the ...

Amgen (NASDAQ:AMGN – Get Free Report) is expected to be issuing its quarterly earnings data after the market closes on ...

Equities research analysts at William Blair reduced their FY2024 earnings per share estimates for shares of Amgen in a ...

The biotech is, however, facing one of the steepest patent cliffs in the biopharma industry, with $4.35 billion TNF inhibitor Enbrel (etanercept) and $2.25 billion psoriasis therapy Otezla ...

With the overall stock market very overbought, the four highest-yielding Dogs of the Dow look like outstanding ideas now.

MANILA, Philippines—Every 10 minutes in 2023, a woman or girl lost her life at the hands of an intimate partner or family member — a chilling reminder of the unrelenting violence women face ...

Back to Healio The second round of Medicare Part D price negotiations will feature two drugs familiar to rheumatologists — Ofev and Otezla — a move applauded by experts as they await the ...